Eli Lilly: Studies suggest key correlation between lung cancer subtype and treatment outcomes
Co In clinical research, patients with advanced non-small cell lung cancer that are classified as having a non-squamous histology achieve statistically significant higher survival when treated in the second-line setting with ALIMTA (pemetrexed for injection) when compared to histologically-similar patients treated with docetaxel.
This entry was posted on Wednesday, September 26th, 2007 at 8:53 am and is filed under Research, Non-Small-Cell. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.